CompuGroup up on Q2 beat, outlook hike

CompuGroup Medical SE & Co KgaA

04/08/2022 08:48

** Shares of German medical software company CompuGroup
Medical  COP1n.DE  are up 4% after a guidance hike and slight Q2
beat  urn:newsml:reuters.com:*:nASM000M4R
    ** Q2 sales rise 10% to 265 mln euros ($270 mln) vs
consensus of 259 mln, while adj. EBITDA was 54 mln euros, a 1.7%
beat on consensus cited by Jefferies
    ** The company now sees revenue of 1.10-1.15 bln euros for
2022 vs original guidance of 1.075-1.125 bln euros, and adj.
EBITDA of 240-260 mln euros against 235-260 mln previously
    ** "We rate CompuGroup highly for its strong market
position, sticky customer base and significant growth
opportunities from the further digitalization of healthcare,"
Jefferies says
    ** The stock is among the top performers of the German
small-cap index  .SDAXI 
($1 = 0.9819 euros)

 (Reporting by Anastasiia Kozlova)
 ((Anastasiia.Kozlova@thomsonreuters.com))